XNAS
TRUP
Market cap1.25bUSD
Oct 20, Last price
28.76USD
1D
4.58%
1Q
17.63%
Jan 2017
85.31%
IPO
147.93%
Name
Trupanion Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Trupanion, Inc., including its various subsidiaries, specializes in offering health insurance for pets, specifically canine and feline companions. This coverage is available to customers through a convenient monthly subscription model across the United States, Canada, Puerto Rico, and Australia. The company strategically divides its operations into two distinct segments: its core Subscription Business and an Other Business division. It caters to a dual clientele, serving both individual pet owners and the broader veterinary community. Founded in 2000, the enterprise initially operated under the name Vetinsurance International, Inc. before officially adopting the Trupanion, Inc. moniker in 2013. Its corporate headquarters are situated in Seattle, Washington.
Key people
Darryl Rawlings
Chairman of the Board · since 2024
Margaret Tooth
President, Chief Executive Officer, Director · since 2024
Fawwad Qureshi
Chief Financial Officer · since 2023
John Gallagher
Chief Operating Officer · since 2024
Steve Weinrauch
Executive Vice President - Veterinary and Product · since 2024
Simon Wheeler
Executive Vice President - International Business · since 2024
Emily Dreyer
Senior Vice President - Channels Growth · since 2022
Brenna Mcgibney
Chief Administrative Officer · since 2022
Murray Low
Lead Independent Director · since 2023
Independent Director · since 2023
Jacqueline Davidson
Independent Director · since 2018
Independent Director · since 2023
Richard Enthoven
Independent Director · since 2023
Independent Director · since 2023
Bradley Powell
Independent Director · since 2025
Howard Rubin
Independent Director · since 2014
Legal address
C/O Corporation Service Company
2711 Centerville Road
Suite 400
Wilmington, DE 19808
US
2711 Centerville Road
Suite 400
Wilmington, DE 19808
US
Headquarters
907 North West Ballard Way
Seattle, WA 98107
US
Seattle, WA 98107
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||